chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a registered nurse refers to a female patient of unknown age. Medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with M-M-R II (dose and frequency were not reported). On unspecified dates, patient had negative titers for measles, mumps and rubella on a recent blood test. Nurse reported that the patient then received two additional "booster" doses of M-M-R II. One administered on 24-JAN-2013 was inadvertently given by the intramuscular rather than subcutaneous route (lot number 0599AA expiration date 24-JAN-2013). No adverse effects were reported by this incident. The second booster administration date was unspecified. Outcome of events was unknown. Causality was not provided. No product quality complaint (PQC) was involved. No further information provided. Additional information has been requested.
A physician reported the inability of a 40-year-old female to respond to the hepatitis B vaccine recombinant (Engerix-B) immunization series. The pt's medical history, concurrent conditions and concurrent medications were unknown. The physician did not believe that the pt was immunocompromised. On unspecified dates, the pt received a series of hepatitis B vaccine (brand unknown) and was found to be nonresponder after the 3rd injection. An additional series of Engerix-B was given "recently" at 0, 1, and 6 months. The 6th injection was given in Oct 2002. A titer measured "a little" after one month after the 6th injection was "negative".
Extreme chills, muscle aches about 5 hours after receiving vaccine. Fever of 103.8 about 10 hours following vaccine as well as extreme headache, fever and chills lasted throughout the night and went down under 100F at about 8am the next day. Very fatigued for the next 2 days until I felt back to "normal".
Second dose of Jynneos was administered on day 18 instead on day 28; Case reference number US-BN-2022-002182 is a spontaneous case report initially received on 31-Aug-2022 from other health care professional via Communication (reference number: USBAV22-1237) and concerns a patient.  The patient's relevant medical history and concomitant medications were not reported.  On 12-Aug-2022, the patient was vaccinated with first dose of Jynneos vaccine (Smallpox and Monkeypox Vaccine, Live, Nonreplicating; batch number: FDP00016) at dose of 0.5 ml, at an unknown route or anatomical site for monkeypox prophylaxis.  On 30-Aug-2022, 18 days after the first dose, the patient was vaccinated with second dose of Jynneos vaccine (Smallpox and Monkeypox Vaccine, Live, Nonreplicating; batch number: FDP00016) at dose of 0.5 ml, at an unknown route or anatomical site for monkeypox prophylaxis (explicitly coded as 'Inappropriate schedule of vaccine administered').  At the time of this report, it was unknown if the patient experienced adverse event.  Additional information received on 31-Aug-2022 from Bavarian Nordic included local BN number.  The case is linked with US-BN-2022-002180, US-BN-2022-002181, US-BN-2022-002182, US-BN-2022-002184 due to the same reporter.; Reporter's Comments: A mala patient, was vaccinated with second dose of Jynneos vaccine, 18 days after the first dose, at dose of 0.5 ml, at an unknown route or anatomical site for monkeypox prophylaxis which is considered as inappropriate schedule of vaccine administered. Inappropriate schedule of product administration is considered listed per company convention. At this point, it was unknown if the patient experienced adverse event due to Jynneos vaccine. The patient's relevant medical history and concomitant medications were not reported. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A mala patient, was vaccinated with second dose of Jynneos vaccine, 18 days after the first dose, at dose of 0.5 ml, at an unknown route or anatomical site for monkeypox prophylaxis which is considered as inappropriate schedule of vaccine administered. Inappropriate schedule of product administration is considered listed per company convention. At this point, it was unknown if the patient experienced adverse event due to Jynneos vaccine. The patient's relevant medical history and concomitant medications were not reported. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.
Case number PHEH2012US017094 is an initial spontaneous report received from a nurse on 27 Aug 2012. This case refers to a patient of unspecified age and gender. The patient was vaccinated with only MenCYW liquid conjugate component of MENVEO vaccine (batch number: Unknown) on an unspecified date. No other information was available.
Breakthrough case admission after 2 vaccine Pfizer 10/11/21 Lot# FF2598;  Pfizer 5/3/22 Lot# FJ4989;
In December 2022, I came down with COVID-19 after taking a test. I contacted my doctor who prescribed me Paxlovid. After taking the treatment, about 7-8 days later, I tested positive again for rebound COVID-19 after having a low-grade fever, body aches, sinus headache, and general cold-like symptoms. I informed my doctor again and was advised to just rest and let it run its course the second time around. Since then, I've recovered with no residual symptoms. About one month later, I was diagnosed with hypertension following my rebound COVID-19 infection.
Two-dose varicella vaccine recipient diagnosed with varicella at ED on 9/1/2014. Reported 400 lesions (macules, papules, and vesicles), no history of chickenpox. No exposures noted.
Information has been received from a nurse practitioner concerning a 25 year old female registered nurse employee with asthma and a history of chicken pox exposure, hypertension, kidney stones, and rash post dibrompropamidine isethionate (+) promethazine and thimerosal. On 8/01/01, a varicella zoster titer was 0.19 (less than or equal to 0.90 is negative; greater than or equal to 1.10 is positive). On 8/10/01 and 9/11/01, the patient was vaccinated with a first and second dose of varicella virus vaccine live (lot # 639782/0844L), respectively. On 5/20/04 at06:45, a varicella zoster titer was collected and the result was 0.44 (less than or equal to 0.90 is negative; greater than or equal to 1.10 is positive). The reporter stated the patient failed to seroconvert and the adverse event was non-responsive by titer. Unspecified medical attention was sought. On 6/13/04 in the PM, the patient was vaccinated SC in the right arm with a third dose of varicella virus vaccine live. A product quality complaint was not involved. Additional information is not expected.
12/1/16 -child presented to clinic with concern for redness and swelling to (L) arm. At home, the evening after vaccines given, redness and swelling began. Patient told mom there was pain and some numbness. The following morning parents noticed swelling from shoulder to elbow and was red. Pain also with movement. Pain improved, but some itchiness, redness also improved. No fever. No treatment needed.
The pt developed a swollen, tender and red area around the site of the injection radiating to the elbow; treated with Augmentin 875mg BID X 10 days.
This spontaneous report was received from a registered nurse and refers to a 19 month old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 27-JUL-2017, the patient was vaccinated with an improperly stored VARIVAX at a dose of 0.5 (units not specified) from lot # N012132 with expiry date: 17-APR-2019 (dose number, route, anatomical location and site of administration were not reported) for prophylaxis. Concomitant medications included a properly stored sterile diluent (manufacturer unknown). The administered dose of vaccine was stored in the temperature between 6 degrees Fahrenheit and 14 degrees Fahrenheit for 20 hours and in the temperature between 15 degrees Fahrenheit and 46 degrees Fahrenheit for 6 hours. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. No additional information was provided. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1707USA004945.
blood clot in my lung; This is a spontaneous report received from a contactable consumer (patient). A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not reported), on unspecified date at single dose for COVID-19 immunization. The patient's medical history included he/she was not a smoker. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162B2, on unspecified date at single dose for COVID-19 immunization. It was reported that patient had been diagnosed with a blood clot in his/her lung shortly after receiving his/her second dose of the COVID vaccine. He/she was not sure if they would be interested in what was going on in his/her case, but patient's doctor said it would be helpful to notify them and that they may be interested in this diagnosis. He/she had his/her legs and many other areas checked out (Ulta sounds etc), but there was no sign of clotting anywhere except for his/her lung so far. He/she was not a smoker and he/she had never had surgery or any major procedures. The outcome of the event was unknown.   Information about lot/batch number has been requested.
9x6 inch hot, erythematous reaction to upper left arm within 48 hours of administration.  Treated with Benadryl 2 tsp every 6 hours.
About 5 days after 3rd dose I had an itchy lump on the back of my neck on the right side. I also had aching in my groin on both sides. About a week after discovering the lump on my neck I discovered a tender bump on the inside of my right thigh. I consulted with two different medical doctors who said they were swollen lymph nodes. Both are still present. In late October I began having itching on the soles of my feet and palms of my hands. After about 7 days it progressed to full body itching. Starting around 11/15/21 I began experiencing hives on a daily basis which have continued to the present. I reported these issues on V-Safe & was told to report them. I advised the person who called that I can?t be 100% certain these symptoms are caused by the vaccine, but I suspected it based on timing. I was told to make a VAERS report. I?m also experiencing bouts of nausea, diarrhea, faintness, brain fog, and bouts of severe abdomen pain that I was not experiencing in the months before the shot.
Cold sores  around mouth and chin. Accompanied by severe nausea. They are still breaking out so unsure how bad yet or if hospital is needed.
My arm hurt really badly the night of the vaccination and the next day. I was tired and achy the next day. No fever. It felt progressively better. Then, about 8 days later, my arm started hurting again.  The next day, a rash appeared in the afternoon. It looked like hives. I went to urgent care to make sure it wasn't cellulitis; it wasn't. The doctor prescribed a topical cortisone cream and an oral prednisone to take if it kept spreading. I started the cream yesterday evening at 6:30 (it is now 7:30 pm). What started as three 1.5" patches on my arm has now grown to one large patch (7" tall and 3" wide). It has also started to itch.
I constantly get chest pains & chest pressure. I admitted to the ER overnight for full testing. Cardiologist noticed irregular heart beats and very abnormal blood pressure. I also experienced uncontrollable shaking/chills for 10 minutes a week after receiving my second shot.
Information has been received from a nurse in a physician's office concerning a pediatric patient who may have been vaccinated with a dose of Varivax (lot # not reported). Subsequently the patient developed a mild case of chickenpox, 8-15 lesions. The patient's outcome was not reported. Additional information has been requested.
Pt developed rash on left arm (the same day of vaccine). Pt had the rash the following day with a fever of 103, nausea, vomiting, body aches. Tx with Rocephin. Suspect meningococcal disease.
Patient states that 1 day after receiving Moderna Booster shot, she had chills/fever. Her husband states that she was "out of it" and had lost consciousness for a bit so they called the paramedics. She went to the ER.
Headache; Nausea; Dizziness; This is a spontaneous report from Pfizer Sponsored Program from a non-contactable consumer (patient).  A patient of unspecified age and gender received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced headache, nausea, dizziness. Outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
6 hours after receiving the shot I started to feel ill.  I started with body aches, slight weakness and a low fever.  Two hours later I had a stinging headache, more weakness, and a much higher fever (101).  I had a restless night of sleep.  In the morning my fever had broken although I still had a very slight fever.  I felt very rundown - which lasted to varying degrees for 4 days.  I later slept approximately 10 hours over a 20 hour period.  The next day my temperature was lower than typical and I felt very rundown.  The following two days I gradually felt better.  I fully felt back to normal 5 days after the shot.  I had no reaction after the first shot.  This shot gave me the harshest reaction.  I had a reaction to my booster shot (3rd shot) but that only lasted 1 and 1/2 days and was generally more mild (a Pfizer vaccine on December 28, 2021).
I am still having  persistent  chills, sore joints, swollen face, and brain fog (cognitive impairment). These symptoms have been persisting since I got the second shot and it has been 6 weeks now. I NEVER had these symptoms prior to the vaccine.
Nurse gave patient a third dose of MMRV when the patient was only due for her kinrix.  This was her third dose of MMR and Varicella
Sore right arm and tiredness tarted about 1.5 hrs after the shot. Around midnight (shot was at 9:25am) more symptoms arose including body aches, raised temperature (100.8° at the highest), headache, nausea, and chills. Ibuprofen taken about 11am on 1/25 (day of shot) and then again around 4am (1/26). Excedrin taken around 9am on 1/26. Temperature and headache lessened with the medicine. Body aches ongoing.
she hasn't been able to move her shoulder; severe pain in her left shoulder; she says she did not receive the vaccine on the deltoid; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOKINESIA (she hasn't been able to move her shoulder), ARTHRALGIA (severe pain in her left shoulder) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (she says she did not receive the vaccine on the deltoid) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included LISINOPRIL for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (she says she did not receive the vaccine on the deltoid). On 28-Mar-2021, the patient experienced HYPOKINESIA (she hasn't been able to move her shoulder) and ARTHRALGIA (severe pain in her left shoulder). On 27-Mar-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (she says she did not receive the vaccine on the deltoid) had resolved. At the time of the report, HYPOKINESIA (she hasn't been able to move her shoulder) and ARTHRALGIA (severe pain in her left shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient took ibuprofen as treatment for the events.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Non-significant follow up appended.
Patient stated that she developed fever and chills the night of the vaccines and the next morning she fainted while walking in her house.
On the day of the vaccination, symptoms included chills, headache, fatigue, and soreness at the injection site. The injection site remained swollen and very sore for 3 days. I took one low-dose aspirin on the day of vaccination.  Approximately 8 days after the injection, a red, itchy rash appeared at the injection site.
Very nauseous; dizzy can't stand; Feeling very sick; head feels heavy; This is a spontaneous report from a contactable consumer reporting for himself. A 65-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EL9264/expiration date: not provided), via an unspecified route of administration, on 20Feb2021 at 13:00 (at the age of 65 years old) as a single dose in the left arm for COVID-19 IMMUNIZATION. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: not provided), via an unspecified route of administration, on an unknown date as a single dose for COVID-19 IMMUNIZATION. Relevant medical history and concomitant medication were not provided. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unspecified date in Feb2021, the patient was very nauseous, dizzy can't stand, feeling very sick, and head feels heavy. The patient did not require hospitalization and did not receive any treatment for these events. At the time of the report, it had been 5 days since the second dose and the outcome of the events nauseous, dizzy can' stand, feeling very sick, and head feels heavy was not recovered.  Since the vaccination, the patient had not been tested for COVID-19.
Redness in hair (R) temple and above (R) ear. 1 day later blister sores same area. Pain in ear, face, lips, mouth, tongue, head. Emergency hospital diagnosed shingles. 24/7 pain. Vertix and Hydrocodin.
Diarrhea; weakness; Fever; Redness; Mild headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), ASTHENIA (weakness), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (Redness) and HEADACHE (Mild headache) in a 98-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced DIARRHOEA (Diarrhea), ASTHENIA (weakness), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (Redness) and HEADACHE (Mild headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea), ASTHENIA (weakness), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (Redness) and HEADACHE (Mild headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.
Client received the vaccine and was sitting for her 15 minute observation period. About 10 minutes into her observation period, client stated she felt dizzy and her neck hurt. RN got an icepack to her neck and was about to get client's jacket off and client fainted. Client was guided to the ground, RN did a sternal rub and after about 15 seconds after initial loss of consciousness, client regained consciousness. Client stated she felt like she was going to vomit and client was turned on her side. Client then stated her lips were numb but denied any SOB. She remained alert and orientated and continued to deny SOB. EMS arrived, client was given fluids, Benadryl, Pepcid, and solumedrol. Client was stable and transported to ER via ambulance
The bivalent booster was given after it's BUD. Beyond Use Date 2/14.
PT WAS FULLY VACCINATED WITH MODERNA. 2/26/21 (LOT 022M20A) + 4/5/21 (LOT 017B21A). S/O 8/23/2021, TESTED + 8/27/2021
Bad flu like symptoms including extreme fatigue, fever of 101, muscle aches, bad headache, sweating
Fainted approximately 5 minutes after administration of second vaccination. Time of unconsciousness was approximately 2 minutes. Patient stated no previous history of fainting.
Information has been received from a consumer concerning her son, a 12 month old male with allergies to formaldehyde and fragrance mix and history of sleep apnea and had tonsils and adenoids who on 10-JAN-2006 was vaccinated with MMR II. There was no concomitant medication. The patient developed the measles within 48 hours of receiving MMR II. The patient did not perform any lab diagnostics study. Subsequently, the patient recovered from the measles. The patient sought medical attention. Additional information is not expected.
Patient presents to the ER for evaluation of fever and reports that the second dose of the vaccine was given 3 days prior to admission.  Patient endorses cough and congestion since that time.  Patient reports onset of fever the day of prior to admission.
extreme fever and inability to focus right eye. Lack of focus in eye is leading to dizziness and headache.
Redness and soreness at injection site. Patient indicates it feels as if the needle is still in the muscle.
LEFT LEG PAIN; HEADACHES; This spontaneous report received from a parent concerned a 25 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, Laboratory data included: Blood test (NR: not provided) normal, and Diagnostic ultrasound (NR: not provided) no findings. On 11-APR-2021, the subject experienced left leg pain. On 11-APR-2021, the subject experienced headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from headaches, and left leg pain. This report was non-serious. This case, from the same reporter is linked to 20210456965.
Pain on injection site with fever at night on the first day. Right arm pain has not subsided until now (3/19/2021). I have ROM but there is a lingering muscular pain??? Pain with certain movement such as raising Right arm or swinging the right arm.